[ORGANIZATION]
ResMed
Featured in 19 tracked stories · first seen
Situations
Seasonal mental health and light exposure impacts
27 clusters · 122 sources · last updated
Latest: Natural light reduction and its impact on autumn fatigue
Discussions regarding seasonal mental health transitions focus on the biological and psychological impacts of changing light levels. Early reports highlight Seasonal Affective Disorder (SAD), a clinical condition involvi
Retatrutide clinical trials for sleep apnea
2 clusters · 8 sources · last updated
Latest: Sleep apnea research highlights new therapies and health risks
Clinical trials, specifically the TRIUMPH-1-OSA and TRIUMPH-2-OSA Phase 3 studies, have indicated that the investigational weight-loss medication retatrutide may significantly reduce the severity of obstructive sleep apn
ResMed quarterly financial performance
2 clusters · 5 sources · last updated
Latest: ResMed reports strong quarterly earnings and dividend
ResMed reported strong financial results for the third quarter of 2026, with revenue reaching $1.41 billion. This figure represented a 5.9% year-on-year increase and exceeded analyst consensus estimates of $1.39 billion.
Wellness trends for mental health and burnout
2 clusters · 9 sources · last updated
Latest: Lifestyle trends address burnout and the need for slower daily routines
Recent wellness trends have emerged to address mental health, cognitive function, and the pressures of modern productivity. Experts suggest that structured morning routines—including regular waking times and exposure to
Global wearable and connected medical technology market
3 clusters · 11 sources · last updated
Latest: Global digital diabetes management market projected to reach $58.1 billion by 2030
The global market for wearable medical technology is projected to expand significantly, with estimates suggesting it could grow from USD 3.98 billion in 2026 to USD 9.97 billion by 2031, representing a compound annual gr
Also covered in
-
ResMed targets 12% to 14% EPS growth amid rising sleep therapy demand
[BUSINESS] · 2 sources ·
-
Tyler Reddick reveals obstructive sleep apnea diagnosis
[SPORTS] · 3 sources ·
-
FDA Issues Class 1 Recall for ResMed Astral Home Ventilators, Advises Continued Use
[HEALTH] · 2 sources ·